Dr. Silvia C. Formenti, MD

Dr. Formenti practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Formenti's NPI, 1568463339, was assigned on August 3, 2005. Dr. Formenti graduated from University of Milan Faculty of Medicine in 1980. Dr. Formenti holds New York license 212254.

Dr. Formenti's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Formenti's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Formenti to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Formenti practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Formenti's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Formenti is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Formenti's licenses on file in 4 states: New York, Florida, California and New Jersey.

Dmand AI lists bone cancer radiation and breast cancer radiation among the conditions Dr. Formenti treats.

CMS data shows 731 Medicare services from Dr. Formenti across 11 procedure codes in 2024, for 80 Medicare patients. Medicare paid $73,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Formenti in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Formenti's median patient age at 72, with 98% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Formenti for performance year 2024, reported through an alternative payment model (APM). Dr. Formenti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Formenti as offering telehealth.

Dmand AI links 202 papers to Dr. Formenti, published from 2004 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Breast Neoplasms, Immunotherapy and Cell Line, Tumor. Dr. Formenti has published most often in Int J Radiat Oncol Biol Phys. Dr. Formenti's most frequent co-authors are Encouse Golden, MD, PhD, Sylvia Adams, MD and Deborah M. Axelrod, MD.

Dmand AI links Dr. Formenti to 21 clinical trials, 8 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Prostatic Neoplasms. Weill Medical College of Cornell University sponsors the most, 12.

CMS Open Payments shows 121 general payments to Dr. Formenti from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. AstraZeneca Pharmaceuticals LP paid the most, $48,742. It also lists 14 research payments totaling $3,309 from 2018 to 2020.

Dmand AI lists 5 awards for Dr. Formenti, most recently America's Top Doctors in 2014.

Dr. Formenti graduated from University of Milan Faculty of Medicine in 1980. Dr. Formenti is a member of ASCO.

Dr. Formenti is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.